abstract |
The invention relates to novel compounds of general formula (I) or pharmaceutically acceptable salts thereof, in the formula R A , R B1 , R B2 , ring A and ring B are as defined in the description, pharmaceutical compositions comprising said compounds and methods of using the compounds as inhibitors of RIP1 kinase. |